Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase

Petersen, 2017, Regulation of hepatic glucose metabolism in health and disease, Nat. Rev. Endocrinol., 13, 572, 10.1038/nrendo.2017.80

Bian, 2017, Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation, Nat. Commun., 8, 10.1038/ncomms14420

Seenappa, 2016, Context dependent regulation of human phosphoenolpyruvate carboxykinase isoforms by DNA promoter methylation and RNA stability, J. Cell. Biochem., 117, 2506, 10.1002/jcb.25543

Kang, 2016, Nuclear mechanisms of insulin resistance, Trends Cell Biol., 26, 341, 10.1016/j.tcb.2016.01.002

Pavlova, 2016, The emerging hallmarks of cancer metabolism, Cell Metab., 23, 27, 10.1016/j.cmet.2015.12.006

Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Montal, 2015, PEPCK coordinates the regulation of central carbon metabolism to promote cancer cell growth, Mol. Cell, 60, 571, 10.1016/j.molcel.2015.09.025

Vincent, 2015, Mitochondrial phosphoenolpyruvate carboxykinase regulates metabolic adaptation and enables glucose-independent tumor growth, Mol. Cell, 60, 195, 10.1016/j.molcel.2015.08.013

Leithner, 2015, PCK2 activation mediates an adaptive response to glucose depletion in lung cancer, Oncogene, 34, 1044, 10.1038/onc.2014.47

Li, 2014, Fructose-1,6-bisphosphatase opposes renal carcinoma progression, Nature, 513, 251, 10.1038/nature13557

Dong, 2013, Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer, Cancer Cell, 23, 316, 10.1016/j.ccr.2013.01.022

Hanson, 2009, Thematic minireview series: a perspective on the biology of phosphoenolpyruvate carboxykinase 55 years after its discovery, J. Biol. Chem., 284, 27021, 10.1074/jbc.R109.040519

Balsa-Martinez, 2015, Cancer cells hijack gluconeogenic enzymes to fuel cell growth, Mol. Cell, 60, 509, 10.1016/j.molcel.2015.11.005

Nye, 2008, Reassessing triglyceride synthesis in adipose tissue, Trends Endocrinol. Metab., 19, 356, 10.1016/j.tem.2008.08.003

Mendez-Lucas, 2014, Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability, J. Biol. Chem., 289, 22090, 10.1074/jbc.M114.566927

Li, 2015, Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors, Cancer Res., 75, 1191, 10.1158/0008-5472.CAN-14-2615

Zhao, 2017, Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells, Oncotarget, 8, 83602, 10.18632/oncotarget.18787

Gao, 2017, Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues, Sci. Rep., 7

Sanders, 2015, Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma, Oncoscience, 2, 151, 10.18632/oncoscience.128

Stark, 2009, Phosphoenolpyruvate cycling via mitochondrial phosphoenolpyruvate carboxykinase links anaplerosis and mitochondrial GTP with insulin secretion, J. Biol. Chem., 284, 26578, 10.1074/jbc.M109.011775

Yang, 2009, What is the metabolic role of phosphoenolpyruvate carboxykinase?, J. Biol. Chem., 284, 27025, 10.1074/jbc.R109.040543

Leithner, 2018, The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells, Proc. Natl. Acad. Sci. U. S. A., 115, 6225, 10.1073/pnas.1719871115

Faubert, 2017, Lactate metabolism in human lung tumors, Cell, 171, 10.1016/j.cell.2017.09.019

Izquierdo-Garcia, 2014, Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase, PLoS One, 9, 10.1371/journal.pone.0108289

Cardaci, 2015, Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis, Nat. Cell Biol., 17, 1317, 10.1038/ncb3233

Lussey-Lepoutre, 2015, Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism, Nat. Commun., 6, 8784, 10.1038/ncomms9784

Lao-On, 2018, Roles of pyruvate carboxylase in human diseases: from diabetes to cancers and infection, J. Mol. Med., 96, 237, 10.1007/s00109-018-1622-0

Alvarez, 2016, Neuronal progenitor maintenance requires lactate metabolism and PEPCK-M-directed cataplerosis, Cereb. Cortex, 26, 1046, 10.1093/cercor/bhu281

Luo, 2017, Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma, Oncogene, 36, 3609, 10.1038/onc.2016.520

Liu, 2018, Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma, Oncogene, 37, 1637, 10.1038/s41388-017-0070-6

Chen, 2011, Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer, PLoS One, 6

Gutteridge, 2017, Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma, Cancer Lett., 394, 13, 10.1016/j.canlet.2017.02.013

Khan, 2015, mTORC2 controls cancer cell survival by modulating gluconeogenesis, Cell Death Discov., 1, 10.1038/cddiscovery.2015.16

Zhang, 2014, Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion, Proc. Natl. Acad. Sci. U. S. A., 111, 10684, 10.1073/pnas.1411026111

Shi, 2016, The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells, Cancer Lett., 382, 147, 10.1016/j.canlet.2016.08.025

Zhao, 2010, Regulation of cellular metabolism by protein lysine acetylation, Science, 327, 1000, 10.1126/science.1179689

Jiang, 2011, Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase, Mol. Cell, 43, 33, 10.1016/j.molcel.2011.04.028

Latorre-Muro, 2018, Dynamic acetylation of phosphoenolpyruvate carboxykinase toggles enzyme activity between gluconeogenic and anaplerotic reactions, Mol. Cell, 71, 718, 10.1016/j.molcel.2018.07.031

Park, 2014, Expression of phosphoenolpyruvate carboxykinase linked to chemoradiation susceptibility of human colon cancer cells, BMC Cancer, 14, 160, 10.1186/1471-2407-14-160

Shang, 2016, The anti-angiogenic effect of dexamethasone in a murine hepatocellular carcinoma model by augmentation of gluconeogenesis pathway in malignant cells, Cancer Chemother. Pharmacol., 77, 1087, 10.1007/s00280-016-3030-x

Ma, 2013, Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma, Nat. Commun., 4, 2508, 10.1038/ncomms3508

Buck, 2017, Metabolic instruction of immunity, Cell, 169, 570, 10.1016/j.cell.2017.04.004

Ho, 2015, Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses, Cell, 162, 1217, 10.1016/j.cell.2015.08.012

Wei, 2015, Lactate promotes PGE2 synthesis and gluconeogenesis in monocytes to benefit the growth of inflammation-associated colorectal tumor, Oncotarget, 6, 16198, 10.18632/oncotarget.3838

Dzugaj, 2006, Localization and regulation of muscle fructose-1,6-bisphosphatase, the key enzyme of glyconeogenesis, Adv. Enzyme Regul., 46, 51, 10.1016/j.advenzreg.2006.01.021

Zhu, 2015, NPM1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells, Oncotarget, 6, 21443, 10.18632/oncotarget.4167

Moore, 2012, Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation, Oncogenesis, 1, e14, 10.1038/oncsis.2012.14

Hirata, 2016, Decreased expression of fructose-1,6-bisphosphatase associates with glucose metabolism and tumor progression in hepatocellular carcinoma, Cancer Res., 76, 3265, 10.1158/0008-5472.CAN-15-2601

Li, 2013, Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells, Mol. Cancer, 12, 110, 10.1186/1476-4598-12-110

Zhang, 2016, Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells, Mol. Cell. Biochem., 411, 331, 10.1007/s11010-015-2595-8

Bigl, 2008, Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancer, Biochem. Biophys. Res. Commun., 377, 720, 10.1016/j.bbrc.2008.10.045

Wu, 2016, ZFX-mediated down-regulation of FBP1 confers to growth in melanoma, Int. J. Clin. Exp. Pathol., 9, 1222

Cairns, 2011, Regulation of cancer cell metabolism, Nat. Rev. Cancer, 11, 85, 10.1038/nrc2981

Li, 2016, Fructose-1,6-bisphosphatase is a novel regulator of Wnt/beta-catenin pathway in breast cancer, Biomed. Pharmacother., 84, 1144, 10.1016/j.biopha.2016.10.050

Chen, 2017, Fructose-1,6-bisphosphatase 1 reduces 18F FDG uptake in hepatocellular carcinoma, Radiology, 161607

Christofk, 2008, The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth, Nature, 452, 230, 10.1038/nature06734

Sabharwal, 2014, Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel?, Nat. Rev. Cancer, 14, 709, 10.1038/nrc3803

Diehn, 2009, Association of reactive oxygen species levels and radioresistance in cancer stem cells, Nature, 458, 780, 10.1038/nature07733

Kondaveeti, 2015, Epithelial–mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines, Cancer Lett., 364, 44, 10.1016/j.canlet.2015.04.025

Hay, 2016, Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?, Nat. Rev. Cancer, 16, 635, 10.1038/nrc.2016.77

Chen, 2015, Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain, Cancer Res., 75, 554, 10.1158/0008-5472.CAN-14-2268

Voehringer, 2000, Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis, Proc. Natl. Acad. Sci. U. S. A., 97, 2680, 10.1073/pnas.97.6.2680

Jin, 2017, Fructose-1,6-bisphosphatase inhibits ERK activation and bypasses gemcitabine resistance in pancreatic cancer by blocking IQGAP1–MAPK interaction, Cancer Res., 77, 4328, 10.1158/0008-5472.CAN-16-3143

Liu, 2010, Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis, Oncogene, 29, 442, 10.1038/onc.2009.332

Mamczur, 2012, Cell cycle-dependent expression and subcellular localization of fructose 1, 6-bisphosphatase, Histochem. Cell Biol., 137, 121, 10.1007/s00418-011-0884-1

Herzog, 2000, Characterization of the human liver fructose-1,6-bisphosphatase gene promoter, Biochem. J., 351, 385, 10.1042/bj3510385

Pan, 2013, Suppression of gluconeogenic gene expression by LSD1-mediated histone demethylation, PLoS One, 8

Wong, 2016, Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis, Hepatology, 63, 474, 10.1002/hep.28304

Sun, 2015, SETDB1 accelerates non-small cell lung cancer (NSCLC) tumorigenesis through WNT signalling pathway, Cancer Res., 75, 2868, 10.1158/1538-7445.AM2015-2868

Koide, 2016, Setdb1 maintains hematopoietic stem and progenitor cells by restricting the ectopic activation of nonhematopoietic genes, Blood, 128, 638, 10.1182/blood-2016-01-694810

Yang, 2017, Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression, Sci. Rep., 7, 43864, 10.1038/srep43864

Jin, 2017, MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation, Oncogenesis, 6, e312, 10.1038/oncsis.2017.21

Kohnhorst, 2017, Identification of a multienzyme complex for glucose metabolism in living cells, J. Biol. Chem., 292, 9191, 10.1074/jbc.M117.783050

Schoors, 2014, Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis, Cell Metab., 19, 37, 10.1016/j.cmet.2013.11.008

Ros, 2012, Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival, Cancer Discov., 2, 328, 10.1158/2159-8290.CD-11-0234

Lee, 2014, TIGAR, TIGAR, burning bright, Cancer Metab., 2, 1, 10.1186/2049-3002-2-1

Ros, 2017, 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells, Oncogene, 36, 3287, 10.1038/onc.2016.477

Barcena-Varela, 2018, Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma, Hepatology, 10.1002/hep.30168

Cong, 2018, Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression, Cell Metab., 28, 245, 10.1016/j.cmet.2018.06.021

Garber, 2016, Cancer anabolic metabolism inhibitors move into clinic, Nat. Biotechnol., 34, 794, 10.1038/nbt0816-794

Kim, 2017, Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy, Hum. Mol. Genet., 26, 1890, 10.1093/hmg/ddx097

Chou, 2010, Glycogen storage disease type I and G6Pase-beta deficiency: etiology and therapy, Nat. Rev. Endocrinol., 6, 676, 10.1038/nrendo.2010.189

Abbadi, 2014, Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion, Mol. Cancer Res., 12, 1547, 10.1158/1541-7786.MCR-14-0106-T

Guo, 2015, Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer, Tumour Biol., 36, 7649, 10.1007/s13277-015-3463-6

Belkaid, 2006, The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression, Cancer Cell Int., 6, 7, 10.1186/1475-2867-6-7

Fortier, 2008, Silencing of the MT1-MMP/G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells, FEBS Lett., 582, 799, 10.1016/j.febslet.2008.01.061

Belkaid, 2006, Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin, FEBS Lett., 580, 3746, 10.1016/j.febslet.2006.05.071

Lord-Dufour, 2009, Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1α: targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells, Stem Cells, 27, 489, 10.1634/stemcells.2008-0855

Wang, 2012, Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, Hepatology, 56, 186, 10.1002/hep.25632

Liu, 2011, Wnt signaling regulates hepatic metabolism, Sci. Signal., 4, ra6, 10.1126/scisignal.2001249

Park, 2007, von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase, Int. J. Oncol., 30, 341

Jiang, 2017, Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis, J. Biol. Chem., 292, 13296, 10.1074/jbc.M117.780130

Hall, 2007, Insulin represses phosphoenolpyruvate carboxykinase gene transcription by causing the rapid disruption of an active transcription complex: a potential epigenetic effect, Mol. Endocrinol., 21, 550, 10.1210/me.2006-0307

Liang, 2013, MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis, J. Hepatol., 58, 535, 10.1016/j.jhep.2012.10.024

Izuishi, 2014, Molecular mechanisms of [18]Ffluorodeoxyglucose accumulation in liver cancer, Oncol. Rep., 31, 701, 10.3892/or.2013.2886

Tahanian, 2010, Inhibition of tubulogenesis and of carcinogen-mediated signaling in brain endothelial cells highlight the antiangiogenic properties of a mumbaistatin analog, Chem. Biol. Drug Des., 75, 481, 10.1111/j.1747-0285.2010.00961.x

Elgogary, 2016, Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer, Proc. Natl. Acad. Sci. U. S. A., 113, E5328, 10.1073/pnas.1611406113

Altman, 2016, From Krebs to clinic: glutamine metabolism to cancer therapy, Nat. Rev. Cancer, 16, 619, 10.1038/nrc.2016.71

Kishton, 2017, Metabolic regulation of T cell longevity and function in tumor immunotherapy, Cell Metab., 26, 94, 10.1016/j.cmet.2017.06.016

Strickaert, 2017, Cancer heterogeneity is not compatible with one unique cancer cell metabolic map, Oncogene, 36, 2637, 10.1038/onc.2016.411

Olson, 2016, Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies, Trends Biochem. Sci., 41, 219, 10.1016/j.tibs.2016.01.002

Liang, 2016, Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma, Biochim. Biophys. Acta, 1866, 177

Menyhárt, 2016, Guidelines for the selection of functional assays to evaluate the hallmarks of cancer, Biochim. Biophys. Acta, 1866, 300

Miller, 2017, Exploring metabolic configurations of single cells within complex tissue microenvironments, Cell Metab., 26, 788, 10.1016/j.cmet.2017.08.014

Nelson, 2017, Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival, Nat. Commun., 8, 14689, 10.1038/ncomms14689

Gautier-Stein, 2012, Glucotoxicity induces glucose-6-phosphatase catalytic unit expression by acting on the interaction of HIF-1alpha with CREB-binding protein, Diabetes, 61, 2451, 10.2337/db11-0986